Codiak BioSciences
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
Org chart
Teams
View all
Discover similar companies
Akoya Biosciences
Series D • San Francisco, United States
BioMarin Pharmaceutical
Post IPO Debt • San Rafael, United States
Exicure
Post IPO Equity • Skokie, United States
BioAge
Series C • Richmond, United States
Enko
Series C • Stonington, United States
Verve Therapeutics
Series B • Cambridge, United States
Biogen
Cambridge, United States
Leapcure
Seed • Los Angeles, United States
Mission Bio
Series C • San Francisco, United States
Genentech
Venture • South San Francisco, United States
Vir Biotechnology
Post IPO Equity • San Francisco, United States
KBI Biopharma
Venture • Durham, United States
helps you hire
great candidates
It’s free to use - try it out today.